Sourcing: single source, treat as unconfirmed until corroborated.
OtherBRIEF
China's Qyuns Therapeutics licenses antibody program to Caldera in up to $780 million deal
Reuters reported on Thu Nov 5, 1:45 PM CT, unconfirmed by other outlets so far: China's Qyuns Therapeutics licenses antibody program to Caldera in up to $780 million deal.
What happened
Reported from Reuters. Site-only brief: it was not posted on X.